Skip to main content
Premium Trial:

Request an Annual Quote

Pfizer-BioNTech Seek Full Vaccine Approval

Pfizer and BioNTech are seeking full approval for their SARS-CoV-2 vaccine from the US Food and Drug Administration, according to the New York Times. In December, the FDA granted an Emergency Use Authorization for the companies' vaccine, which enabled it to be rolled out across the US.

With a full approval, Pfizer and BioNTech would be able to directly market their vaccine to consumers, and having approval could make it easier for companies, schools, and government agencies to require vaccinations, the Times adds.

CNBC notes that it typically takes the FDA at least a year to determine whether a drug is safe and effective for general use, but adds that Pfizer and BioNTech are seeking approval through a rolling submission process that may be faster as the agency can review data as it receives it.

"We are proud of the tremendous progress we've made since December in delivering vaccines to millions of Americans in collaboration with the US government," Albert Bourla, the CEO and chair of Pfizer, says in a statement. "We look forward to working with the FDA to complete this rolling submission and support their review, with the goal of securing full regulatory approval of the vaccine in the coming months."

The Times adds that FDA is expected to issue an EUA allowing the Pfizer-BioNTech vaccine to be given to 12- to 15-year-olds.

Moderna, CNBC says, is also expected to seek full approval for its vaccine later this month.

The Scan

Study Examines Relationship Between Cellular Metabolism, DNA Damage Repair

A new study in Molecular Systems Biology finds that an antioxidant enzyme shifts from mitochondria to the nucleus as part of the DNA damage response.

Stem Cell Systems Targets Metastatic Melanoma in Mouse Model

Researchers in Science Translational Medicine describe a pair of stem cell systems aimed at boosting immune responses against metastatic melanoma in the brain.

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.

Neurological Outcomes Linked to Innate Immune Features After Cardiac Arrest

Researchers reporting in Med dig into immune features found a few hours after cardiac arrest that correspond with neurological outcomes.